Introduction: Klebsiella pneumoniae is an uncommon cause of meningitis - most cases are associated with nosocomial infection. In the United States and Europe, an estimated 8% of nosocomial bacterial infections can be attributed to K. pneumoniae, and predominantly manifest as urinary and respiratory tract infections. From past reports, gram negative bacilli made up only 3% of community acquired meningitis cases, although higher rates are described in Southeast Asia. We report a case of meningitis due to community-acquired Klebsiella with a rare stroke-like presentation secondary to meningitis-associated vasculitis. Case Report: A 57 year-old man with diabetes mellitus and hypertension presented with confusion, fever, and left-sided hemiplegia for the preceding four days. He was obtunded and intubated. Lumbar puncture yielded cerebrospinal fluid (CSF) with a white blood cell count of 53,600cells/mm3 with 95% neutrophils, glucose <1mg/dL and protein of 474.3mg/dL. The patient was started on vancomycin, ceftriaxone and dexamethasone. CSF gram stain was significant for gram negative bacilli that speciated to Klebsiella pneumoniae and dexamethasone was discontinued. Magnetic resonance imaging was performed, which showed arteritis of the right middle cerebral artery, bilateral ventriculitis and acute infarction of the right cerebellar hemisphere. By hospital day (HD) two, the patient demonstrated improved strength in his left upper and lower extremities. On HD 3 patient's left sided weakness returned and his mental status worsened. Steroids were restarted-again with improvement within 12 hours. Extensive evaluation for a source of Klebsiella, including abdominal imaging, cultures of urine and blood and echocardiography yielded no findings outside the central nervous system. In addition, other causes of vasculitis were not found. Treatment included a 21-day course of ceftriaxone and a tapered 14-day course of steroids. Minimal residual left-sided motor deficit remained and patient was transferred to the rehabilitation service. Discussion: Review of the literature confirmed the rarity of community acquired Klebsiella meningitis with no significant prior healthcare exposure. Age and underlying diabetes mellitus are predisposing factors in this patient. Steroid-responsive neurological findings consistent with vasculitis further added to the novelty of our patient's presentation. Klebsiella meningitis animal models have demonstrated increased synthesis of pro-inflammatory markers such as, TNF-alpha, IL-1 and IL-6 with subsequent neurological and cognitive deficits. This patient's Klebsiella isolate had hypermucoviscous characteristics similar to those described in case series from Southeast Asia, mainly Taiwan. Steroids in the management of Klebsiella meningitis has not been previously described given the rarity of this clinical syndrome.
Keywords
Health care; Health care facilities; Bacterial meningitis; Infectious diseases; Bacterial infections; Nosocomial infections; Ischemic stroke; Heart; Cardiac function; Cardiovascular function; Cardiopulmonary function; Vasoactive agents; Urogenital system; Respiratory infections; Bacteria; Case reports; Microorganisms; Immune reaction; Blood vessels; Men; Blood sugar disorders; Hypertension; Cerebrospinal fluid; Cerebrovascular system; Steroids; Medicinal chemicals; Drug therapy; Antibacterial agents; Antibiotics; Neurological reactions; Cognitive function
Contact
V. Murthy, New York University School of Medicine, New York, NY
CODEN
AJCMED
Publication Date
20150501
Document Type
Abstract
Email Address
murthv01@nyumc.org
Funding Type
Cooperative Agreement
Fiscal Year
2015
Identifying No.
Cooperative-Agreement-Number-U01-OH-010726
ISSN
1073-449X
Source Name
American Journal of Respiratory and Critical Care Medicine
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.